Pan European Prospective Observational Study of Fremanezumab effectiveness in patients with chronic or episodic migraine in the Real-World: PEARL study

07/05/2020
21/05/2025
EU PAS number:
EUPAS35111
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
Study, other information
English (1.09 MB - PDF) View document
Publications